[ad_1]
Gilead Sciences announced plans to help India alleviate the shortage of remdesivir, a drug widely used to treat Covid-19, as the country is on track to record new infections.
The California pharmaceutical company said in a statement Monday afternoon that it would provide “technical assistance” to partners to issue a voluntary license, help create new manufacturing facilities and provide a key component to “rapidly increase production” of remdesivir.
The company said its seven licensees in India have “significantly accelerated production of remdesivir” by increasing the size of their batches, adding new manufacturing facilities and involving other contract manufacturers across the country.
Gilead said that “although these efforts are expected to increase the availability of remdesivir in the coming weeks, it will provide at least 450,000 anti-virus flashbacks to India to” help alleviate the need for immediate treatment. “
Remdesivir was once said to be a miraculous drug to treat Covid-19, but last year the World Health Organization concluded that it had no significant effect on the patient’s chances of survival. However, India has been an important part of the efforts to treat the coronavirus.
India has recently set a record for the number of new cases of coronavirus reported in any country in a single day, and the proliferation of infections has put its hospital system in serious condition. If the New Delhi authorities have it he banned its use oxygen cylinders, except for key industries.
In mid-April, India remdesivir has blocked exports worried there would be a shortage of drugs. A few days later, more than 800 shots of the drug they were stolen From the Bhopal government hospital in Madhya Pradesh state, increasing supply restrictions.
Europe and the United Kingdom They are ready to increase support for India. The Biden administration said Monday it would be sent by the U.S. 60m dose Oxford / AstraZeneca Covid-19 vaccine abroad. If the White House hadn’t said where the blows were supposed to go, it would probably be in high demand in India.
[ad_2]
Source link
